Boiron acquires Spain's Hivital Labs, its first major acquisition in 20 years
By taking over a specialist in food supplements sold mainly online, the Messimy-based laboratory has acquired a range and a distribution channel distinct from its historical business. The transaction, already completed, is to be financed from available cash.
A portfolio of 70 product references, sold mainly online in Europe
Les Laboratoires Boiron announced on 16 November 2026 that it had completed the acquisition of 100% of the share capital of Hivital Labs, a Spanish company that develops and sells food supplements online. This is a completed acquisition, not an agreement pending conditions precedent.
According to the group, this transaction is its first significant acquisition in more than 20 years. It is presented as an important step in the vision set out at the start of 2025, which pursues two objectives: strengthening Boiron's position in the food supplements market and developing its presence in online commerce.
Founded in 2018 by Ferran Forcada and based near Barcelona, Hivital Labs designs and sells a range of around 70 product references. This range covers in particular longevity, immunity, sleep and stress, digestion, joints and general well-being.
The company sells its products mainly in Spain, Germany, Italy and France. Its model is based on direct sales to consumers, essentially via the internet: large e-commerce platforms and its own websites constitute its main channel, supplemented by specialised distributors.
For Boiron, a laboratory known for its homeopathic medicines, the interest of the transaction lies in this dual contribution. The group acquires an already established food supplement offering, as well as online distribution expertise that the press release attributes to Hivital Labs, through its digital marketing expertise and its knowledge of consumer expectations.
Financing from cash reserves and preserved autonomy
The acquisition is to be financed from the group's available cash. The Central Works Council representing employees issued a positive opinion on the project, and the board of directors approved it unanimously.
In terms of organisation, Hivital Labs joins the Boiron group while retaining its brand, its teams and its operational autonomy. Its founder, Ferran Forcada, remains at the head of the company as chief executive officer and reports directly to Pascal Houdayer, chief executive officer of Laboratoires Boiron.
This structure reflects a logic of complementarity rather than absorption. According to the press release, Hivital Labs will be able to rely on Boiron's scientific and regulatory expertise, its international network, as well as its industrial and logistics capabilities to support its long-term development.
Conversely, the group highlights the Spanish company's ability to quickly evolve its offering thanks to its mastery of digital marketing.
The transaction should allow Boiron to broaden its range of health and well-being solutions and consolidate its presence in the food supplements market, while strengthening its position in online sales.
Management invokes a shared vision of integrative health
Pascal Houdayer justified the combination by the proximity of the two companies. “The journey of Hivital Labs and the entrepreneurial momentum driven by Ferran convinced us from our first discussions,” the executive said.
He added that the two companies share “a common vision of integrative health, in which prevention and well-being occupy a central place, as well as highly complementary expertise.”
The chief executive officer mentioned the opening of a new phase of development for Hivital Labs, “while respecting its identity, its agility and its entrepreneurial spirit.”